FBN2 and Marfan syndrome: With the consent of the patient and family, and approval from the hospital ethics committee, a whole-exome sequencing family genetic screening was performed, and revealed a heterozygous mutation in FBN2, c.6583C > T supporting the diagnosis of variant Marfan syndrome, with the mother being wild-type and her son showing the heterozygous mutation (Figure 2).